Bruker Corp
BRKR
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.35B
Close$
$8.99
83.6% downside
Current Fair Value
83.6% downsideOvervalued by 83.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.35 Billion |
|---|---|
| Enterprise Value | $10.52 Billion |
| Dividend Yield | $0.20 (0.36%) |
| Earnings per Share | $-0.15 |
| Beta | 1.22 |
| Outstanding Shares | 152,200,000 |
Return
| Return on Equity | -2.97% |
|---|---|
| Return on Assets | -1.18% |
| Return on Invested Capital | 0.51% |
Valuation & Multiples
| P/E Ratio | -78.4 |
|---|---|
| PEG | 10 |
| Price to Sales | 2.49 |
| Price to Book Ratio | 3.65 |
| Enterprise Value to Revenue | 3.01 |
| Enterprise Value to EBIT | 429.58 |
| Enterprise Value to Net Income | -148 |
| Total Debt to Enterprise | 0.22 |
| Debt to Equity | 0.98 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$0.38
Average shareholder expectationRevenue Estimate
$853.57 M
Average shareholder expectationNext Earnings Call
Expected Date
November 2, 2026
EPS Estimate
$0.42
Average shareholder expectationRevenue Estimate
$865.16 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 12.34% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.03%▼ 94.36% |
|---|---|
| Total Invested | $2.54M▼ 99.97% |
| Investors Holding | 12▼ 420.00% |
ESG Score
No data
About Bruker Corp
6,000 employees
CEO: Frank Laukien Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable...